Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
08/17/2005 | CN1653885A Method for obtaining amphihaploid plant of pumpkin ovule and its special culture medium |
08/17/2005 | CN1215083C Monoclonal antibody for resisting human liver cancer and its application |
08/16/2005 | US6930226 Nucleotide sequences coding polypeptide for use in the adjustment of the starch concentration in plant |
08/16/2005 | US6930224 by way of transfecting and/or regenerating plant material under specified culture conditions which prevent or reduce the rate of or delay the rise in pH of the culture medium |
08/16/2005 | US6930182 Composition and methods of using the Mirabilis mosaic caulimovirus sub-genomic transcript (Sgt) promoter for plant genetic engineering |
08/16/2005 | US6930174 CCR5 chemokine receptor-specific antibodies |
08/16/2005 | US6930172 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/16/2005 | US6930169 Reducing induced apoptosis; obtain sample, incubate with modulator, monitor sample for reduction in apoptitic activity |
08/16/2005 | US6930094 Tissue factor for influencing blood vessel formation |
08/16/2005 | US6929948 Lineage specific cells and progenitor cells |
08/16/2005 | US6929947 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/16/2005 | US6929938 25501, a human transferase family member and uses therefor |
08/16/2005 | US6929937 Human transferase proteins and polynucleotides encoding the same |
08/16/2005 | US6929933 genes for riboflavin biosynthesis in yeast, the proteins encoded therewith and genetic engineering process for the preparation of riboflavin starting from GTP using these genes and gene products |
08/16/2005 | US6929932 An isolated polynucleotide molecule encoding an IL-21 antagonist polypeptide of specefic amino acid sequence; culturing |
08/16/2005 | US6929930 Nucleotide sequences coding antigenic peptide for use in diagnosis of bacterial infections |
08/16/2005 | US6929924 eliminates all interference due to proinsulin and its intermediates, in particular des-31,32-proinsulin and/or des-64,65-proinsulin |
08/16/2005 | US6929921 Antibody which binds human blue-light photoreceptor hCRY2 |
08/16/2005 | US6929907 Used for detecting incomplete deprotection of a synthetic oligonucleotide by immunoassay |
08/16/2005 | US6929792 administering to a patient genetically modified dendritic cells which are to express on the cell surface, an E/L-selectin chimera that contains the transmembrane and intracellular domains of L-selectin and extracellular domain of E-selectin |
08/16/2005 | CA2141025C Anti-mucus glycoprotein monoclonal antibody |
08/16/2005 | CA2084075C The ciliary neurotrophic factor receptor |
08/11/2005 | WO2005073396A1 Plant cells having receptor polypeptides |
08/11/2005 | WO2005073395A1 Method of examining ability to regulate the expression of neprilysin activity |
08/11/2005 | WO2005073386A1 Composition and method for immobilizing genetic material on support and transferring into cell |
08/11/2005 | WO2005073366A1 Method for isolating and culturing multipotent progenitor/stem cells from umbilical cord blood and method for inducing differentiation thereof |
08/11/2005 | WO2005073365A1 Method of treating cells for transplantation, cell suspension, prosthesis for transplantation and method of treating injured site |
08/11/2005 | WO2005072764A2 Fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells |
08/11/2005 | WO2005072515A1 High lycopene tomato varieties and use thereof |
08/11/2005 | WO2005072364A2 A modified baculovirus expression system for production of pseudotyped raav vector |
08/11/2005 | WO2005072125A2 Composite materials for controlled release of water soluble products |
08/11/2005 | WO2005072112A2 Methods for producing and identifying multispecific antibodies |
08/11/2005 | WO2005059119A3 Differentiated cells |
08/11/2005 | WO2005046617A3 Compositions and methods for reducing microbial induced apoptosis |
08/11/2005 | WO2005039662A3 Cartilage regeneration by generation of chondrons under high concentrations of magnesium |
08/11/2005 | WO2004101758A3 Composition for maintaining organ and cell viability |
08/11/2005 | WO2004094602A3 Combinatorial surface chip compositions for selection, differentiation and propagation of cells |
08/11/2005 | WO2004088283A3 Apparatus and methods for providing sex-sorted animal sperm |
08/11/2005 | WO2004083394A3 Human g protein-coupled receptors and modulators thereof for the treatment of inflammatory disorders |
08/11/2005 | WO2004050842A3 Atm kinase compositions and methods |
08/11/2005 | WO2004030626A3 In vitro culture of tissue structures |
08/11/2005 | WO2004009766A3 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
08/11/2005 | WO2003088899A3 Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof |
08/11/2005 | WO2003077836A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
08/11/2005 | US20050177904 Inbred corn line D603 |
08/11/2005 | US20050177895 Inbred corn line KW4U110 |
08/11/2005 | US20050177894 Inbred corn line D501 |
08/11/2005 | US20050177893 Transcription factors and methods for introduction of value-added seed traits and stress tolerance |
08/11/2005 | US20050177890 Transposon being functional in mammals |
08/11/2005 | US20050177882 Method and system for fusion and activation following nuclear transfer in reconstructed embryos |
08/11/2005 | US20050176946 Constitutive promoter from Arabidopsis |
08/11/2005 | US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders |
08/11/2005 | US20050176933 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents |
08/11/2005 | US20050176930 Nucleotide sequences coding tumor associated antigen for use in diagnosis, prevention and treatment of cell proliferative disorders; mimetics; antitumor agents |
08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
08/11/2005 | US20050176659 Polypeptide contributing to regulating the metabolism of triglycerides; obesity as well as related disorders such as eating disorder, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone, cancers of the reproductive organs |
08/11/2005 | US20050176640 poxvirus protein A41L binds to leukocyte common-antigen-related protein; monoclonal antibody; therapeutic agents for an immune and/or inflammatory response; poxvirus |
08/11/2005 | US20050176147 Method for obtaining a cell model capable of reproducing in vitro the metabolic idiosyncrasy of humans |
08/11/2005 | US20050176144 Culture media compositions free of fetal bovine serum |
08/11/2005 | US20050176143 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
08/11/2005 | US20050176142 Mammalian megakaryocyte progenitor cell |
08/11/2005 | US20050176141 Compositions and methods relating to culturing neural stem cells with bone marrow stromal cells |
08/11/2005 | US20050176140 Method and apparatus for cell culture using a two liquid phase bioreactor |
08/11/2005 | US20050176137 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
08/11/2005 | US20050176132 Culture device and method for eukaryotic cell transfection |
08/11/2005 | US20050176129 Adenovirus vector |
08/11/2005 | US20050176117 Using sterospecific carboxylesterase variant for bioremediation of pyrethroids |
08/11/2005 | US20050176104 Using overexpression of nucleotide sequences coding tumor associated antigen as diagnostic/prognostic tool in detection of cancer |
08/11/2005 | US20050176102 Totipotent hematopoietic stem cell receptors and their ligands |
08/11/2005 | US20050176094 Polypeptide having immunomodulatory activity, antiviral activity, and antitumor activity; polynucleotides, expression vectors , probes and antibodies; predicting responsiveness to treatment with interferon- alpha and other interferons which act at the Type 1 interferon receptor |
08/11/2005 | US20050176083 Blood protein fusion comprising serine-protease (SP) domain for use in treatment of thrombosis a nd blood coagulation disorders |
08/11/2005 | US20050176044 Polynucleotides and polypeptides encoding receptors |
08/11/2005 | US20050176041 Using membrane proteins as tool in diagnosis, prevention and treatment of cell proliferative disorders |
08/11/2005 | US20050176022 Vertebrate telomerase genes and proteins and uses thereof |
08/11/2005 | US20050176018 Increased nuclease resistance; gene expression inhibition |
08/11/2005 | US20050176013 Identifying modulators of 3'-phosphoadenosine 5'-phosphosulfate synthase 1(PAPPS-1) activity; antitumor agents; tumor diagnostics |
08/11/2005 | US20050176005 Functional ligand display |
08/11/2005 | US20050175986 Human monoclonal antibody |
08/11/2005 | US20050175978 Methods and devices for mecroencapsulation of cells |
08/11/2005 | US20050175976 Meiosis activating sterol augments implantation rate |
08/11/2005 | US20050175705 Modified reconstituted basement membrane composition for assay system |
08/11/2005 | US20050175606 Cyclic single-chain trispecific antibody |
08/11/2005 | US20050175599 Process for producing substance |
08/11/2005 | US20050175596 Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells |
08/11/2005 | US20050175590 Viral expression vectors |
08/11/2005 | US20050175587 Inhibits cancer cell growth especially epithelial cancer cell growth; host cell and a drug containing the vector; for the treatment of cancers, by gene therapy |
08/11/2005 | US20050173315 Tangential flow filtration devices and methods for leukocyte enrichment |
08/11/2005 | DE102004025080A1 Method for testing substances for their effects on cells, useful e.g. in screening for pharmaceuticals or cosmetics, using organoid bodies derived from adult stem cells |
08/11/2005 | CA2554825A1 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
08/11/2005 | CA2554599A1 Novel brain natriuretic peptide variants and methods of use thereof |
08/11/2005 | CA2554410A1 Biotherapeutics, diagnostics and research reagents |
08/11/2005 | CA2554403A1 Gastrointestinal proliferative factor and uses thereof |
08/11/2005 | CA2553989A1 Production of host cells containing mutiple integrating vectors by serial transduction |
08/10/2005 | EP1561822A1 Detection of DNA damaging agents |
08/10/2005 | EP1561817A2 Modified CEA and uses thereof |
08/10/2005 | EP1561815A2 Tissue-specific and target rna-specific ribozymes |
08/10/2005 | EP1561814A1 Gene expressed specifically in dopamine-producing neuron precursor cells after termination of division |
08/10/2005 | EP1560916A1 Expansion agents for stem cells |
08/10/2005 | EP1560915A2 Assay methods for state-dependent calcium channel agonists/antagonists |
08/10/2005 | EP1560587A1 Cholesterol efflux and uses thereof |